FindTrial
Sign In

Risk factors and prognosis of heart valve sugery in patients with sleep disordered breathing

Risk factors and prognosis of heart valve sugery in patients with sleep disordered breathing

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OCH-12002757
Enrollment
Unknown
Registered
2012-11-29
Start date
2012-11-01
Completion date
Unknown
Last updated
2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

sleep apnea

Interventions

Case series:Nil

Sponsors

The First Affiliated Hospital of Nanjing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1) aged between 18 to 70 years; (2) with symptomatic stable heart failure, New York Heart Association (NYHA) class >=II despite optimal drug therapy; and (3) a primary episode of rheumatic fever and current rheumatic heart disease based on 2002 to 2003 WHO criteria for the diagnosis of rheumatic fever and rheumatic heart disease.

Exclusion criteria

Exclusion criteria: (1) history of stroke or clinical signs of peripheral or central nervous system disorders; (2)chronic obstructive pulmonary disease or history of asthma; (3) enrolment in another clinical study

Design outcomes

Primary

MeasureTime frame
apnea/hypopnea index;—

Secondary

MeasureTime frame
SPO2;the use of vasoactive agents;ICU stay time;mechanical ventilation time ;—

Countries

China

Contacts

Public ContactShi-Jiang Zhang
shijiangzhang@hotmail.com+86 13901596786

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026